Clinical Benefit, Harm, and Cost Effectiveness of Screening Men for Peripheral Artery Disease: A Markov Model Based on the VIVA Trial

CONCLUSION: Screening of men for PAD is likely to be both clinically effective and cost effective in a lifetime perspective.PMID:33846075 | DOI:10.1016/j.ejvs.2021.02.039

Source: PubMed: Eur J Vasc Endovasc ... - April 13, 2021 Category: Surgery Authors: Jes S Lindholt Rikke S øgaard Source Type: research